OCRA’s Schreiber Research Grants Program supports postdoctoral fellows, early career independent investigators, and teams of experienced investigators. Since 1998, OCRA has invested $110 million in ovarian cancer research, and has awarded more than 350 grants to top scientists at over 75 leading medical centers. We invest our dollars wisely, supporting the best ovarian cancer research in the nation. With an annual grantmaking budget of $6 – 7 million, OCRA is the largest charity funding ovarian cancer research in the United States.
OCRA’s Schreiber Research Grants Program is named after Ann and Sol Schreiber, founders of Ovarian Cancer Research Alliance.
OCRA 2023 Grant Cycle
2024 timeline will be posted in early 2023
|Letter of Intent (LOI) Opens||March 7, 2022||Passed|
|Letter of Intent (LOI) Due||April 7, 2022||Passed|
|Full Proposal Due||June 22, 2022||Passed|
|Grant Notification||End of September 2022||Passed|
If you would like to join our grant opportunities mailing list so you will be informed about future grant announcements, please send an email to email@example.com.